New patent for Taiho Oncology drug LONSURF

   May 15, 2021    Comments Off on New patent for Taiho Oncology drug LONSURF    Posted in: Patent Added

Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are four patents…

The post New patent for Taiho Oncology drug LONSURF appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog